ANAB and TRAX Related Headlines
Go Back- H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)
- AnaptysBio authorizes $100 million stock buyback plan
- Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
- AnaptysBio (ANAB) PT Raised to $66 at H.C. Wainwright
- Guggenheim on AnaptysBio (ANAB) Spinoff: 'Additional potential upside may be derived from imsidolimab in generalized pustular psoriasis'
- Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
ANAB and TRAX Related Press Releases
Go Back- Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
- Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
